NCT02569307 - Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States | Biotech Hunter

Enrollment

326

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

March 31, 2019

Conditions

At Risk Mental State (ARMS)Psychosis

Interventions

DRUG

Minocycline

Minocycline added to TAU Minocycline will be administered in 200mg once daily dose

DRUG

Omega-3 fatty acids

Omega-3 fatty acids added to TAU Omega-3 fatty acids will be administered in 1.2g once daily dose

DRUG

Placebo

Placebo added to TAU

DRUG

Minocycline Plus Omega-3 fatty acids

Minocycline will be administered in 200mg once daily dose and Omega-3 fatty acid 1.2g taken as once daily dose

Trial Locations (7)

Abasi Shaheed Hospital, Karachi

Civil hospital Karachi, Karachi

Karwn e Hayat, Karachi

Colleges and Universities, Karachi

Community, Karachi

General Practitioners (GPs), Karachi

Institute of Behavioral Sciences, Karachi

All Listed Sponsors

lead

Pakistan Institute of Living and Learning

OTHER